Look Back Icon

NextGen Omics, Spatial & Data US 2026


Thank You For Attending

Together, we can accelerate life changing, targeted, treatments.

The event featured engaging content and discussions across the entire multi-omics portfolio, underscoring our collective commitment to advancing multi-omics R&D.

NGO US Look Back Image-1

Lights, Camera, Action!

Explore our curated photo gallery of standout moments from NextGen Omics, Spatial & Data US 2026. See if you can spot yourself!

Day One Highlights

onsite NGOUS

Decoding Immunotherapy

Arutha Kulasinghe opened the event to explore how spatial omics & high-plex profiling are transforming analysis of the tumour microenvironment.

onsite NGOUS (1)

Genomics, But Not as You Know It

Jackson Brougher shared how genomics is being used to better understand & reduce risk in human spaceflight, with insights from the EXPAND program.

onsite NGOUS (2)

Multi-Omics After Hours

Heatmap Happy Hour brought everyone together to unwind, swap ideas, & keep the multi-omics conversations going, with plenty of cocktails had throughout the evening.

Day Two Highlights

4ee2b179-75b1-4d7b-9714-189025100d73

Inclusive Leadership in Practice

This breakfast session brought delegates together to explore inclusive leadership, with insights from Aridaman Pandit on turning intent into tangible impact. 

ngb onsite (5)

When Spatial Data Comes Together

The GESTALT workshop highlights the value of connected datasets and collaborative thinking in driving more meaningful insights from spatial biology. 

ngb onsite (2)

Making Multi-Omics Work in the Clinic

Led by Sunwha Kim, this discussion focuses on predicting response, integrating complex datasets, and what still needs to be solved. 

Lights, Camera, Action!

Explore our curated photo gallery of standout moments from NextGen Omics & Spatial Biology US 2025. See if you can spot yourself!

NextGen Biomed 2025

Advancing Therapeutic Innovation Through Multi-Omics Research  

NextGen Omics & Spatial Biology connects thought leaders, researchers, and experts with pharmaceutical & biotech representatives to discuss the latest innovations across the fields of multi-omics. 

There are three dedicated programmes running across two full days, which together will explore multi-omics from technological development to therapeutic applications and analysis, making this a must-attend event for anyone working in clinical diagnostics, single cell & spatial biology. 

Hear from past attendees of last year's Biologics 2024 conference

Explore the NextGen Omics & Spatial Biology US 2025 Programme

Antibody Society

NextGen Biomed 2025 is supported by our
Scientific Programme Partner The Antibody Society

What's been happening at NextGen Omics & Spatial Biology US 2025?

Have a peek into the dynamic panels, engaging roundtables, and hands-on workshops happening in Boston - right now!

spatial biology Track keynote address 
 Spatial Multi-Omics For Target-To-Disease Linkage In Inflammatory Diseases

MARINA BLECK, Principal Scientist, Boehringer Ingelheim

Marina discussed the use of multi omics for faster Faster Target-to- Disease Link (T2DL) with increased confidence and how they can leverage Spatial Biology to enhance the ability to derive insight from human disease tissues.  Finally the Importance of FFPE Tissue Quality for Spatial Biology was discussed with the use of QC scoring to determine which FFPE tissue gives the best spatial transcriptomics results.

spatial biology day one, track 6 
Spatial Biology As A Discovery Pathway

EMRE ARSLAN, Takeda

Emre Arslan from Takeda gave a talk about the use of Spatial Biology as a discovery pathway. First of all providing an update on the current landscape for spatial technologies then analysing how spatial technologies can be used in clinical trial design - such as the ability to identify previously unknown cell types, interactions and microenvironments and providing an ideal foundation for training better AI models. 

day 2 keynote
Single Cell into Spatial and Beyond: Landscape in 2025 and What’s Next?

JASMINE PLUMMER, Director, St Jude Children's Research Hosptial

Jasmine Plummer's day 2 keynote focused on Single cell into spatial and beyond.  "The reason we are in this room is because it’s cutting edge" which is why the single cell and spatial field growing exponentially.

Future directions for the technology include Low throughput, clinical trials, other organisms, more tissue types, epigenomics

Spatial multi-omics, track 4 Keynote
Rapid Single-Cell Spatial Proteomics by Spatial MIST

JUN WANG, Associate Professor, Multiplex Biotechnology Laboratory, Department of Biomedical Engineering, Stony Brook University

"Simpler but more powerful than flow and imaging cytometry"

MIST Technology provides100 times more information than flow cytometry and currently the highest multiplexity is up to 500 markers/ cell.

Single cell track keynote address
Panel Application Of Single Cell Omics In Clinical Monitoring

PRIYA CHOCKALINGAM, Vice President, Head of Clinical BioAnalytics & Translational Sciences, Beam Therapeutics

Priya's talk focused on Genome Editing Technologies for Gene & Cell Therapy and how cell & gene therapies require a specialized regulatory approach compared to other modalities. Appropriate assessments should therefore be put in place in both nonclinical and clinical stages to address safety concerns.

Various methods to assess off-target editing effects have evolved in the last decade. However, limitations remain in balancing accuracy vs sensitivity of these new techniques.

The direct assessment of off-target effects in vivo and in patients is particularly challenging.

Novel single-cell technologies enable quantitation/co-occurrence of on-/off-target editing through patient time-course of treatment

single cell  
Comparative Insights In Single Cell RNA-seq & Advances In Large-Scale Multimodal Profiling

ZORA MODRUSAN, Senior Director NGS, Genentech

Zora focused on both key insights and future directions of single cell RNA-Seq.  scRNA-seq technologies were evaluated and the differences in performance across various metrics such as sensitivity, throughput and cost were compared across different systems.

The Overloading And unpacKing (OAK) method provides a reliable solution for large-scale molecular profiling that incorporates multiple data modalities.

Moving forward they will continue to evaluate the latest scRNA-seq kits to understand differences and guide optimal performance. Zora would also like to enhance OAK's capabilities by integrating additional modalities and applying the platform to a wide range of biological systems.

Our 2026 Speakers

Elaine Joseph
Director, Precision Medicine,
AstraZeneca
Enrico Mossotto
Senior Director,
MeiraGTx
Giorgio Gaglia
Head of Systems Biology,
Sanofi US R&D
Jing He
Associate Director,
Novo Nordisk
Zora Modrusan
Senior Director of Genomics,
Genentech
Aarno Palotie
Research Director of the Human Genomics Program,
The University of Helsinki, Institute for Molecular Medicine Finland FIMM
Aaron Berlin
Chief Technology Officer,
Singular Genomics
Abeer Obaid
Senior Scientist,
Abbvie
Aditi Singh
Director of Bioinformatics,
Wayne State University
Ahmet Coskun
Professor of Biomedical Engineering,
Georgia Institute of Technology
Alex Tamburino
Director, Spatial & Single Cell Multiomics,
Merck & Co
Ali Ebrahimi
Associate Director,
Takeda
Alina Ainbinder
Principal Scientist,
Takeda
Amanda Dy
PhD Candidate,
Toronto Metropolitan University, PIcc
Amit Mitra
Associate Professor,
Auburn University
Andrew Owens
Application Scientist,
Mission Bio
Anita Bansal
Associate Director, Lead Translational Bioinformatics,
UCB Pharma
Arutha Kulasinghe
Associate Professor,
The University of Queensland
Ashot Harutyunyan
Academic Associate,
McGill University
Aziz Al'Khafaji
Director, Molecular R&D,
Broad Institute of MIT and Harvard
Aziz Al'Khafaji
Director, Molecular R&D,
Broad Institute of MIT and Harvard
Banishree Saha
Associate Director, Global Biomarker and Assay Analytical Lead,
Takeda Pharmaceuticals
Bharat Thyagarajan
Associate Professor,
University of Minnesota
Carina Emery
Lead Product Manager,
Miltenyi Biotec
Carol Hu
Senior Scientist,
Merck Research Laboratories
Chandra Saravanan
Director, Pathology,
Novartis
Chanyoung Park
Research Scientist,
Stellaromics
Colin McDowell
Senior Manager, Business Development,
Biodesix
Colles Price
Co-Founder & Chief Executive Officer,
TALOX
Daniel Carney
Sales Director,
Fovus
Daniel Jones
Staff Scientist,
Fred Hutchinson Cancer Research Center
David Gallegos
Senior Scientist,
Takeda
Di He
Senior Scientist,
Merck
Dr. Deepak Veeregowda
Chief Executive Officer,
QT Sense
Dulguun Amgalan
Staff Scientist,
Illumina AI Lab
Emre Arslan
Associate Director,
Takeda
Eugenia Lyashenko
Senior Principal Scientist, Lab Head,
Sanofi
Fei Chen
Principal Investigator & Assistant Professor,
Broad Institute
Fei Zou
Professor,
University of North Carolina
Fengbo Ren
Founder and CEO,
Fovus
Gabor Balazsi
Henry Laufer Professor,
Stony Brook University
Gervaise Henry
Vice President, Solutions Engineering,
Manifold AI
Gloria Pryhuber
Professor, Department of Pediatrics, Neonatology (SMD),
URMC
Greg Warner
Senior Field Applications Scientist,
Cell Signaling Technology
Gregory Mendez
Principal Scientist,
Sanofi
Gulpreet Kaur
Chief Businesss Officer,
Elucidate Bio
Hagai Marmor-Kollet
Investment Associate,
aMoon Fund
Hansueli Meyer
Senior Director, Site Leader and Head of Systems Integration Spatial Technologies,
Miltenyi Biotec
Heather Knight
Senior Scientist I,
Abbvie
Hua Li
Director of Computational Biology,
Stowers Institute for Medical Research
Ioannis Ragoussis
Professor,
McGill University
Irene Ghobrial
Professor of Medicine, Senior Vice President of Experimental Therapy, Lavine Family Chair for Preventative Cancer Therapy,
Dana-Farber Cancer Institute
Isabella Polic
Graduate Student,
The University of Texas MD Anderson Cancer Center
Iulian Pruteanu-Malinici
Senior Director Bioinformatics,
Flagship Pioneering
Ivan Lebedev
President,
Verdant Center for Spatial Biology
Jackson Brougher
Assistant Professor & Space Health Research Scientist,
Translational Research Institute For Space Health
Jan Schejbal
Senior Scientist,
AbbVie
Jeff Byland
Senior Science & Technology Advisor,
10x Genomics
Jeff June
Chief Executive Officer,
Ischemia Care
Jennifer Frahm
Director, Field Application Scientist,
Standard BioTools
Jia-Ren Lin
Technical Director of Tissue Imaging,
Harvard Medical School
Jiang He
Vice President,
Vizgen
Jiwoon Park
Founder of the Spatial Atlas of Human Anatomy,
Weill Cornell Medicine
Joann Arce
Assistant Professor,
Boston Children's Hospital, Harvard Medical School
Jochen Lennerz
Chair,
EFLM Task Group on Integrated Diagnostics
John Gillespie
Chief Executive Officer,
Ambergen
Joseph Beechem
CSO & Sr. VP of Research & Development,
Bruker Spatial Biology
Kisha Sivanathan
Senior Scientist,
AstraZeneca
Leonard Lipovich
Professor, Biology and Biotechnology,
Wenzhou-Kean University
Madhumala Sadanandappa
Scientist,
Dartmouth Health
Mahmud Hossain
Senior Scientist II,
Sanofi
Manisha Brahmachary
Associate Director,
Sanofi USA
Manoj Kandpal
Director of Research Bioinfo,
Rockefeller University
Maria Forero
Senior Advisor,
Accelmed
Nicolas Fernandez
Senior Computational Scientist,
Broad Institute of MIT and Harvard
Nir Ben Chetrit
Assistant Professor | PI,
Weill Cornell Medicine
Pei Chen
Principal Scientist,
BMS
Qingqing Wang
Associate Director,
Regeneron
Rapolas Žilionis
Chief Scientific Officer,
Atrandi Biosciences
Rea Dabelic
Senior Staff Product Manager,
Illumina
Sahil Seth
Principal Scientist,
Bristol Myers Squibb
Samouil Farhi
Director, Spatial Technology Platform,
Broad Institute
Samuel Harrison
Technology and Application Science,
Miltenyi Biotec
Sara Hamon
Executive Director, Precision Medicine,
Regeneron Pharmaceuticals
Saum Ghodoussipour
Associate Professor,
Rutgers University
Shanye Yin
Assistant Professor,
Albert Einstein College of Medicine
Sharvari Gujja
Data Scientist, Abbvie,
Abbvie Inc.
Shoh Asano
Senior Principal Scientist,
Pfizer
Shou-Jiang Gao
Professor,
University of Pittsburgh School of Medicine
Silvia Siso
Scientist-Pathologist,
Abbvie
Silvia Siso
Scientist-Pathologist,
Abbvie
Simona Cristea
Head of Genomics and AI,
Dana-Farber Cancer Institute
Sindi Nexhipi
PostDoc,
DKFZ
Sophia George
Professor,
University of Miami
Soumya Negi
Senior Advisor,
Eli Lilly
Sourav Choudhury
Group Head, Distinguished Scientist,
Sanofi
Stephen Baylin
Head of the Cancer Genetics and Epigenetics Program,
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Steven Barthel
Assistant Professor of Dermatology,
Harvard Medical Scool, Mass General Brigham
Suhas Vasaikar
Associate Director,
Pfizer
Sunhwa Kim
Precision Medicine Immunology, Associate Scientific Director,
AbbVie
Terry Melim
Sr Research Analyst,
Abbvie
Tesfaye Mersha
Professor,
Indiana University School of Medicine
Tad George
Senior Vice President Biology R&D,
RareCyte Inc
Tibby Duan
Senior STOmics Product Manager,
Complete Genomics
Tim Harris
Venture Partner,
SV Health Investors
Uttiya Basu
Professor,
Columbia University
Vinay Mohta
Chief Executive Officer & Co-Founder,
Manifold AI
Virginia Savova
Senior Director,
AstraZeneca
Vitalay Fomin
CEO,
Numenos
William Henley
Co-Founder and VP of Research & Innovation,
Codetta Bio
Xuyu Qian
Assistant Professor, Department of Pediatrics, Division of Neurology,
Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania
Yea Jin Kaeser-Woo
Senior Director,
Eli Lilly and Company
Yufei Huang
Professor,
University of Pittsburgh
Zongmei Gao
senior scientist ii,
abbvie

Interested in Sponsoring NextGen Omics & Spatial Biology US 2025?

Become a driving force in accelerating the next generation of multi-omics-based treatments. NextGen Omics & Spatial Biology US offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, & academic experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, & collaborate with the community shaping the future of genomic medicine today.

Interested in Sponsoring NextGen Biomed?

Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.

Interested in Sponsoring NextGen Omics, Spatial & Data US 2027?

Become a driving force in accelerating the next generation of multi-omics-based treatments. NextGen Omics, Spatial & Data US offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, & academic experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, & collaborate with the community shaping the future of medicine today as they scale and commercialize their research.
Pre Med + LSX Combined Logo

Unlock the Latest News and Insights

Sign-up for our regular LifeScienceXchange newsletter to keep up to date with all things Precision Medicine, direct to your inbox.

Pre Med Newsletter Icon-1

Interested in NextGen Omics, Spatial & Data US 2027?